AllianceBernstein’s Abiomed Inc ABMD Stock Holding History

AllianceBernstein’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,202,638	Closed	-$295M	–	3324
2022 Q3	$295M	Buy	1,202,638 +22,726	+2%	+$6.14M	0.14%	143
2022 Q2	$292M	Buy	1,179,912 +22,390	+2%	+$6.04M	0.13%	148
2022 Q1	$383M	Buy	1,157,522 +70,904	+7%	+$21.8M	0.15%	134
2021 Q4	$390M	Buy	1,086,618 +106,551	+11%	+$36M	0.14%	144
2021 Q3	$319M	Buy	980,067 +139,295	+17%	+$47.2M	0.13%	154
2021 Q2	$262M	Buy	840,772 +25,478	+3%	+$7.82M	0.11%	178
2021 Q1	$260M	Buy	815,294 +5,300	+0.7%	+$1.7M	0.11%	176
2020 Q4	$263M	Buy	809,994 +78,839	+11%	+$21.8M	0.12%	147
2020 Q3	$203M	Sell	731,155 -36,348	-5%	-$10.5M	0.11%	158
2020 Q2	$185M	Sell	767,503 -394,230	-34%	-$79.2M	0.11%	164
2020 Q1	$169M	Buy	1,161,733 +209,455	+22%	+$34.8M	0.12%	155
2019 Q4	$162M	Buy	952,278 +364,505	+62%	+$67.6M	0.09%	198
2019 Q3	$105M	Buy	587,773 +519,426	+760%	+$112M	0.07%	298
2019 Q2	$17.8M	Sell	68,347 -10,863	-14%	-$2.88M	0.01%	835
2019 Q1	$22.6M	Buy	79,210 +556	+0.7%	+$185K	0.01%	762
2018 Q4	$25.6M	Buy	78,654 +65	+0.1%	+$22.6K	0.02%	677
2018 Q3	$35.3M	Sell	78,589 -12,624	-14%	-$4.98M	0.02%	626
2018 Q2	$37.3M	Buy	91,213 +34,720	+61%	+$12.6M	0.03%	609
2018 Q1	$16.4M	Sell	56,493 -2,269	-4%	-$575K	0.01%	825
2017 Q4	$11M	Sell	58,762 -54	-0.1%	-$10.1K	0.01%	927
2017 Q3	$9.92M	Sell	58,816 -4,239	-7%	-$641K	0.01%	950
2017 Q2	$9.04M	Sell	63,055 -3,064	-5%	-$412K	0.01%	962
2017 Q1	$8.28M	Buy	66,119 +22,313	+51%	+$2.59M	0.01%	985
2016 Q4	$4.94M	Buy	43,806 +18,590	+74%	+$2.15M	﹤0.01%	1201
2016 Q3	$3.24M	Buy	25,216 +10	+0%	+$1.2K	﹤0.01%	1415
2016 Q2	$2.75M	Sell	25,206 -45,300	-64%	-$4.51M	﹤0.01%	1446
2016 Q1	$6.68M	Buy	70,506 +1,708	+2%	+$144K	0.01%	949
2015 Q4	$6.21M	Sell	68,798 -1,500	-2%	-$127K	0.01%	996
2015 Q3	$6.52M	Buy	70,298 +200	+0.3%	+$17.6K	0.01%	971
2015 Q2	$4.61M	Buy	70,098 +200	+0.3%	+$13.3K	﹤0.01%	1154
2015 Q1	$5M	Buy	69,898 +3,000	+4%	+$163K	﹤0.01%	1124
2014 Q4	$2.55M	Hold	66,898	–	–	﹤0.01%	1563
2014 Q3	$1.66M	Sell	66,898 -300	-0.4%	-$7.6K	﹤0.01%	1859
2014 Q2	$1.69M	Sell	67,198 -68	-0.1%	-$1.58K	﹤0.01%	1908
2014 Q1	$1.75M	Buy	67,266 +68	+0.1%	+$1.88K	﹤0.01%	1811
2013 Q4	$1.8M	Sell	67,198 -7,303	-10%	-$180K	﹤0.01%	1794
2013 Q3	$1.42M	Buy	74,501 +1,806	+2%	+$41.3K	﹤0.01%	1920
2013 Q2	$1.57M	Buy	+72,695	New	+$1.46M	﹤0.01%	1786

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AllianceBernstein's ABMD Position: Q4 2022 in Review

AllianceBernstein sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,202,638 shares — an estimated $295M sold.

AllianceBernstein first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $390M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

AllianceBernstein reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
AllianceBernstein sold 1,202,638 Abiomed Inc shares in Q4 2022, an estimated $295M.
AllianceBernstein first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
AllianceBernstein's Abiomed Inc position peaked at $390M in Q4 2021.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on AllianceBernstein's 13F filing for Q4 2022, filed 15 Feb 2023.